AB Science S.A. (ABSCF)
OTCMKTS · Delayed Price · Currency is USD
1.260
-0.340 (-21.25%)
At close: Jun 6, 2025
AB Science Market Cap
AB Science has a market cap or net worth of $98.58 million as of September 4, 2025. Its market cap has increased by 51.92% in one year.
Market Cap
98.58M
Enterprise Value
110.79M
Revenue
1.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.26
Market Cap Chart
Since April 26, 2010, AB Science's market cap has decreased from 509.55M to 98.58M, a decrease of -80.65%. That is a compound annual growth rate of -10.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 98.58M | 65.47% |
| Dec 31, 2024 | 59.58M | -70.21% |
| Dec 29, 2023 | 199.98M | -43.68% |
| Dec 30, 2022 | 355.08M | -44.48% |
| Dec 31, 2021 | 639.50M | -41.61% |
| Dec 31, 2020 | 1.10B | 311.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 757.64M |
| Tian'an Technology Group | 660.01M |
| Glass House Brands | 561.06M |
| Northwest Biotherapeutics | 393.37M |
| CytoDyn | 391.17M |
| American Oncology Network | 361.55M |